Wednesday, July 8, 2026

pharma · Lymphoma · Gastrointestinal Stromal Tumors · COGT

Cogent Biosciences

Cogent Biosciences clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451, US HQ
2014 Founded
283 Employees
Public company Type
COGT · NYSE Ticker
Company details
Status
Public
HQ
275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451, US
Founded
2014
Employees
283
Programs
13
Drugs
8
Patents
10
Intelligence · Clinical Programs

Cogent Biosciences projects

1 ClinicalTrials.gov programs sponsored by Cogent Biosciences.

Cogent Biosciences has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CGT9486 plus sunitinib

    Cogent Biosciences

    Advanced Gastrointestinal Stromal Tumors

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Cogent Biosciences have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.